PACS Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
48 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 20.33
- PEG ratio
- 1.35
- P/B
- 7.02
- P/S (TTM)
- 1.34
- EV/EBITDA
- 23.40
Profitability & growth
- ROE (TTM)
- 27.1%
- Operating margin
- 8.5%
- Revenue growth YoY
- 11.2%
- Dividend yield
- —
- Beta
- -0.08
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About PACS Group, Inc.
Company profilePACS Group, Inc. is a prominent technology solutions provider dedicated to improving operational efficiency across various sectors through innovative software and hardware systems. The company prioritizes research and development to leverage emerging technological trends and drive digital transformation initiatives. With a strong portfolio of strategic collaborations and a solid market presence, PACS Group is well-positioned for sustainable growth, making it an attractive investment proposition for institutional investors seeking to participate in the rapidly evolving technology landscape.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 90 S. 400 W, SALT LAKE CITY, UT
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
